August 23, 2014 1:55 PM ET


Company Overview of Bristol-Myers Squibb Sarl

Executive Profile

Peter R. Dolan BA,MBA

AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 6 different industries.

See Board Relationships


Prof. Peter R. Dolan, BA, MBA served as Chief Executive Officer of Bristol-Myers Squibb Co. from May 1, 2001 to September 2006 and served as its President from January 2000 to May 1, 2001. Prof. Dolan served as the Chief Executive Officer of Bristol-Myers Squibb Sarl (also known as Bristol-Myers Squibb France) since May 1, 2001 and its President since January 2000. He served as the Chairman and the Chief Executive Officer of Gemin X Pharmaceuticals, Inc. Inc., from 2009 ...

Corporate Headquarters

3 Rue Joseph Monier
Rueil Malmaison, Ile-de-France 92500


Phone: 33 1 58 83 60 00
Fax: 33 1 58 83 60 01

Board Members Memberships

Senior Independent Director
Former Director
Former Chairman of the Board, Chief Executive Officer and President
Former Director


BA 1978
Tufts University
MBA 1980
Tuck School of Business at Dartmouth

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bristol-Myers Squibb Sarl, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at